[Clinical pathway in Chinese county for lung cancer diagnosis and treatment (2023 edition)].

报销 医学 肺癌 癌症 中国 重症监护医学 医疗保健 肿瘤科 内科学 政治学 经济增长 经济 法学
作者
Yi‐Long Wu,Qing Zhou
出处
期刊:PubMed [National Institutes of Health]
卷期号:46 (1): 19-39
标识
DOI:10.3760/cma.j.cn112152-20230928-00162
摘要

Lung cancer (LC) is the leading cause of death among patients with cancer both in worldwide and China. China accounts for 11.4% of the total number of cancer cases and 18.0% of the total number of cancer deaths in the world. Standardizing the diagnosis and treatment of LC is a key measure to improve the survival rate of LC patients and reduce the mortality rate. However, county hospitals generally face the problem of inaccessibility to advanced diagnostic and treatment technologies. Therefore, when developing quality control standards and clinical diagnosis and treatment specifications, it is necessary to combine the actual situation of county hospitals and formulate specific recommendations. The recommendations of treatment measures also need to consider the approval status of indications and whether it is included in the National Reimbursement Drug List (NRDL), to ensure the access to medicines. In order to solve the above problems, based on existing guidelines at home and abroad and the clinical work characteristics of county hospitals, the first clinical pathway in Chinese county for LC diagnosis and treatment (2023 edition) was compiled. This pathway elaborated on the imaging diagnosis, pathological diagnosis, molecular testing, and precision medicine based on histological-pathological types, tumor-node-metastasis (TNM) classification, and molecular classification, developed different diagnosis and treatment processes for different types of LC patients. Simultaneously, according to the actual work situation of county hospitals, the diagnosis and treatment recommendations in clinical scenarios are divided into basic strategies and optional strategies for elaboration. The basic strategies are the standards that county hospitals must meet, while the optional strategies provide more choices for hospitals, which are convenient for county doctors to put into clinical practice. All the recommended diagnostic and treatment plans strictly refer to existing guidelines and consensus, ensuring the scientificity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sunrise完成签到,获得积分10
1秒前
cc发布了新的文献求助10
2秒前
梨花雨凉完成签到,获得积分10
2秒前
3秒前
JamesPei应助Jason采纳,获得10
4秒前
yiyi发布了新的文献求助10
5秒前
闵嘉嘉完成签到,获得积分10
5秒前
H黄发布了新的文献求助30
6秒前
老迟到的羊完成签到 ,获得积分10
7秒前
7秒前
情怀应助科研通管家采纳,获得10
7秒前
充电宝应助科研通管家采纳,获得10
7秒前
SH应助科研通管家采纳,获得10
7秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
搜集达人应助科研通管家采纳,获得10
8秒前
香蕉觅云应助科研通管家采纳,获得10
8秒前
情怀应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
8秒前
酷波er应助科研通管家采纳,获得10
8秒前
拼豆豆应助科研通管家采纳,获得10
8秒前
SH应助科研通管家采纳,获得10
8秒前
隐形曼青应助科研通管家采纳,获得10
8秒前
8秒前
CIAN完成签到,获得积分10
9秒前
9秒前
9秒前
科目三应助科研通管家采纳,获得10
9秒前
领导范儿应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
9秒前
脑洞疼应助科研通管家采纳,获得10
9秒前
9秒前
3G就是牛应助科研通管家采纳,获得10
9秒前
9秒前
英俊的铭应助科研通管家采纳,获得10
9秒前
9秒前
小马甲应助科研通管家采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
适配Micro-LED色转换的高兼容性量子点负性光刻胶制备与工艺研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7315340
求助须知:如何正确求助?哪些是违规求助? 8931459
关于积分的说明 18932025
捐赠科研通 6975537
什么是DOI,文献DOI怎么找? 3213853
关于科研通互助平台的介绍 2381836
邀请新用户注册赠送积分活动 2192369